The Swedish Biologics Register is funded by the Swedish Rheumatology Association, with support from half a dozen pharmaceutical companies. Dr. Ljung disclosed ties with AbbVie and Bristol-Myers Squibb.
News
Successful anti-TNF therapy may cancel excess coronary risk in RA
Publish date: November 19, 2013
AT THE ACR ANNUAL MEETING